Abstract :
[en] Osteoporosis affects millions of elderly patients, and
anti-resorptive drugs (ARD) such as bisphosphonates (BP) represent the first-line
therapy. Despite the benefits related to the use of these medications,
osteonecrosis of the jaw is a significant complication in a subset of patients
receiving these drugs. CASE PRESENTATION: This report documents a case of
dramatic bisphosphonate-related osteonecrosis associated with periodontitis and
dental implant removal in an osteoporotic patient treated with per os
bisphosphonates for an uninterrupted period of 15 years. CONCLUSION: The aim of
this report was to discuss the administration period of BP in the treatment of
osteoporosis, the decision-making and clinical management of severe MRONJ and the
indications for dental implant placement in these specific patients.
Scopus citations®
without self-citations
19